| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424171100 | Binds allergen or component thereof | 6 |
| 20080254041 | Method for Selecting an Immunotherapeutic Preparation - The present invention relates to a method for selecting one or more immunotherapeutic preparation having improved properties as a vaccine against a target antigen, said method comprising raising antibodies against a group of candidate preparations and selecting one or more preparations which produces antibodies having higher affinity against the target antigen than does anti-bodies raised against at least one other preparation from the group. More particularly it relates to the need to provide recombinant allergens (Bet V 1) for SIT which have been modified by protein engineering. | 10-16-2008 |
| 20090035319 | Antibodies Against C3a Receptor - The present invention relates to antibodies and related molecules that specifically bind to C3a Receptor. Such antibodies have uses, for example, in the prevention and treatment of asthma, allergy, and other related inflammatory and immune disorders. The invention also relates to nucleic acid molecules encoding anti-C3a Receptor antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same. The present invention relates to methods and compositions for preventing, detecting, diagnosing, treating or ameliorating a disease or disorder, especially inflammatory and other related disorders, comprising administering to an animal, preferably a human, an effective amount of one or more antibodies or fragments or variants thereof, or related molecules, that specifically bind to C3a Receptor. | 02-05-2009 |
| 20090104208 | House Dust Mite Allergen - A polypeptide comprising an amino acid sequence having at least 60% identity to the amino acid sequence SEQ ID No. 1 or comprising at least one amino acid fragment of at least 6 consecutive amino acid residues of the amino acid sequence SEQ ID No. 1 or having immunological cross-reactivity to the amino acid sequence SEQ ID No. 1 or fragments thereof, wherein the amino acid sequence SEQ ID No. 1 codes for an allergen and the polypeptide comprises at least one T cell epitope recognized by a T cell receptor specific for a molecule having the amino acid sequence SEQ ID No. 1. | 04-23-2009 |
| 20090117131 | Pharmaceutical Composition for The Treatment or Prevention of Allergic Diseases, Use Thereof, and A Method for The Treatment or Prevention of Allergic Diseases - The present invention provides a pharmaceutical composition for preventing or treating allergic diseases comprising histamine and allergen-specific antibody as active ingredients. Also, the present invention provides a use of the above composition for the manufacture of medicament for preventing or treating allergic diseases. Further, the present invention provides a method of preventing or treating allergic diseases which comprises administrating the above pharmaceutical composition to a mammal. When the pharmaceutical composition of the present invention is administered to a mammal, a specific allergic immune response (hypersensitive immune response) to antigen inducing allergic reaction (allergen) that can not be effectively controlled by current standard pharmacological treatments can be effectively suppressed. Therefore, refractory allergic diseases that cannot be sufficiently improved by the current standard pharmacological treatments can be effectively improved if the pharmaceutical composition of the present invention, its use for preventing or treating allergic diseases, or a method of preventing or treating allergic diseases by the above composition is applied. | 05-07-2009 |
| 20130011415 | MILK DERIVED ANTIGEN SPECIFIC ANTIBODIES FOR INDUCING AN ADAPTIVE IMMUNE RESPONSE, METHODS OF PREPARATION AND USES THEREOF - The invention relates to the field of antibodies. In particular the invention relates to milk-derived antigen specific antibodies for generating an adaptive immune response, methods of preparation, and uses thereof. | 01-10-2013 |
| 20130236475 | METHODS FOR REDUCING ALLERGIES CAUSED BY ENVIRONMENTAL ALLERGENS - Compositions suitable for reducing symptoms of an allergic response to environmental allergens comprising molecules that specifically inhibit the ability of the allergen to bind to mast cells in an animal predisposed to having an allergic response to the allergen and methods for reducing such symptoms comprising contacting a source of the environmental allergen with such compositions. Kits, packages, medicaments, and means of communicating about the compositions and methods are also provided. | 09-12-2013 |
